P073-0429 Screening compound: N-(2-{1-benzyl-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-2,2-dimethylpropanamide

P073-0429 Screening compound: N-(2-{1-benzyl-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-2,2-dimethylpropanamide
P073-0429 Screening compound: N-(2-{1-benzyl-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-2,2-dimethylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P073-0429
N-(2-{1-benzyl-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-2,2-dimethylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P073-0429

Molecular Formula

C20H24N4O2 (C20 H24 N4 O2)

Compound Name

N-(2-{1-benzyl-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-3-yl}ethyl)-2,2-dimethylpropanamide

IUPAC name

N-(2-{1-benzyl-2-oxo-1H2H3H-imidazo[45-b]pyridin-3-yl}ethyl)-22-dimethylpropanamide

SMILES

CC(C)(C)C(NCCN(c(nccc1)c1N1Cc2ccccc2)C1=O)=O

InChI

InChI=1S/C20H24N4O2/c1-20(2,3)18(25)22-12-13-23-17-16(10-7-11-21-17)24(19(23)26)14-15-8-5-4-6-9-15/h4-11H,12-14H2,1-3H3,(H,22,25)

InChI Key

YHELGANTLLLGSL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27562384

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

352.44

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.124

Distribution Coefficient, logD

3.124

Water Solubility, LogSw

-3.22

Polar Surface Area

52.956

Acid Dissociation Constant (pKa)

14.54

Base Dissociation Constant (pKb)

1.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

P073-0429 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P073-0429 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P073-0429?
Check Price and Availability of P073-0429, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P073-0429 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P073-0429
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P073-0429
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P073-0429 available by request